Imaging agent
From Wikipedia, the free encyclopedia
Imaging agents are chemicals designed to allow clinicians to determine whether a mass is benign or malignant and locate metastatic cancer sites in the body.
The development of an imaging agent involves synthesizing the agent to target a particular tumor or process, and then adjusting the imaging instruments to neutralize the target. Such agents can are first examined via preclinical animal studies before engaging in early-phase human clinical studies.
[edit] See also
 |
This oncology article is a stub. You can help Wikipedia by expanding it. |
